Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00483821 · ClinicalTrials.gov registry record

A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC

A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.

Completed
Registry status
165
Enrollment target

NCT00483821 is a clinical trial that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 165 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00483821 has completed, sponsored by Vanderbilt-Ingram Cancer Center.

COMPLETED
Registry status
165 participants
Enrollment target

Study Summary

RATIONALE: Gathering disease-related information from medical charts of patients with primary head and neck cancer who have undergone neck dissection after complete response to chemotherapy and radiation therapy may help doctors learn more about the disease and find better methods of treatment. PURPOSE: This clinical trial is evaluating the medical charts of patients with primary head and neck cancer who have undergone neck dissection after complete response to chemotherapy and radiation therapy.

Interventions

  • OTHER medical chart review

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2004-05
Est. Completion 2009-11

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

What the Registry Record Tells You About NCT00483821

The ClinicalTrials.gov registry entry for NCT00483821 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which medical chart review is the first listed.

NCT00483821 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00483821 about?

NCT00483821 is a clinical study titled "A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC". RATIONALE: Gathering disease-related information from medical charts of patients with primary head and neck cancer who have undergone neck dissection after complete response to chemotherapy and radiation therapy may help doctors learn more about the disease and find better methods of treatment. PUR...

What is the current status of trial NCT00483821?

This trial is currently completed. The enrollment target is 165 participants. The study started on 2004-05. Estimated completion is 2009-11.

What interventions are being tested in trial NCT00483821?

The interventions under investigation include: medical chart review (OTHER).

Who is sponsoring clinical trial NCT00483821?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.